SGFG
IDXX icon

Silver Grove Financial Group’s Idexx Laboratories IDXX Stock Holding History

Silver Grove Financial Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.3K Buy
164
+142
+645% +$79.6K 0.05% 278
2026
Q1 		$12.4K Buy
+22
New +$14.1K 0.01% 295

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Silver Grove Financial Group's IDXX Position: Q2 2026 in Review

Silver Grove Financial Group increased its Idexx Laboratories (IDXX) stake by 645% in Q2 2026, buying an estimated $79.6K and bringing the position to 164 shares worth $86.3K. The position accounts for 0.05% of the portfolio, ranked #278.

Silver Grove Financial Group first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Silver Grove Financial Group held 164 shares of Idexx Laboratories worth $86.3K as of Q2 2026.
  • Silver Grove Financial Group bought 142 Idexx Laboratories shares in Q2 2026, an estimated $79.6K.
  • Idexx Laboratories made up 0.05% of Silver Grove Financial Group's portfolio in Q2 2026, its #278 holding.
  • Silver Grove Financial Group first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.